Oxford BioMedica Announced as Regenerative Medicine and Cell Therapy Funding Competition Winner by the UK’s innovation agency, the Technology Strategy Board
— Funding to be received for the development of a novel therapeutic treatment to engineer corneas to resist graft rejection — Oxford, UK – 14 August 2013: Oxford BioMedica plc (“Oxford…